Assistant Adjunct Professor
University of California, San Diego
La Jolla, USA
http://pharmacy.ucsd.edu/faculty/bios/neto.shtml
Jair Siqueira-Neto has a Bachelor degree in Biology and PhD in Genetics & Molecular Biology from Unicamp, where he graduated in 2007 studying the telomere biology of Leishmania parasites. After, he went to South Korea for a post-doc at the recently founded Institut Pasteur Korea, where he pioneered the development of High-Content High-Throughput Screening assays for drug discovery against leishmaniasis. As Staff Scientist and later Team Leader he was involved in drug discovery programs against the parasites Leishmania and Trypanosoma cruzi, working in projects with the Drugs for Neglected Diseases Initiative (DNDi) collaborating with a number of pharmaceutical companies including Pfizer, GlaxoSmithKline, Sanofi, Merck, Astra Zeneca, among others. In 2013 he moved to the Silicon Valley as the Kinetoplastid Core Director at the Center for Discovery and Innovation in Parasitic Diseases (CDIPD), University of California San Francisco – USA. He led projects and collaborations to accelerate the development of new chemotherapies for the kinetoplastid-caused parasitic diseases: leishmaniasis, Chagas disease and Human African Trypanosomiasis. In the summer of 2014 he was hired as Assist. Adj. Professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego where he is currently involved in the construction of a Screening Platform to foster drug discovery and development for neglected and rare diseases with low economical interest from the major pharmas.
